[Tissue plasminogen activator: mechanism of action and thrombolytic properties].
D000818:Animals; D001808:Blood Vessels / Q000378:metabolism; D004285:Dogs; D004727:Endothelium / Q000378:metabolism; D005337:Fibrin / Q000378:metabolism; D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy; D010960:Plasminogen Activators / Q000378:metabolism / Q000502:physiology* / Q000627:therapeutic use; D013300:Streptokinase / Q000627:therapeutic use; D013927:Thrombosis / Q000188:drug therapy; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use; D000979:alpha-2-Antiplasmin / Q000502:physiology
D005343:Fibrinolytic Agents; D000979:alpha-2-Antiplasmin; D005337:Fibrin; D013300:Streptokinase; D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator
Activador tisular del plasminógeno: mecanismo de acción y propiedades trombolíticas.